Why Humana Inc (HUM) Stock Is Rising
As of 2026-11-12, Humana Inc (HUM) has a next-year EPS growth estimate of 95.40%. Featured in 2 EPS revision reports, most recently on 2026-06-09.
Why HUM Stock Is Rising
- +EPS Estimate Upgraded: Analysts raised Humana Inc's next-year EPS growth estimate from 85.62% to 89.40% on 2026-11-06.
- →Estimate Trending Higher: Since detection, the estimate has moved up a net +6.00 pp to 95.40% across 1 upward revision.
- !Largest Single-Day Revision: +6.43 pp on 2026-11-09 (89.40% → 95.83%).
- ·Current-Year Growth: Projected at -44.52%, supporting the forward estimate revision.
News Context
HUM has been rising primarily because analysts upgraded next-year EPS growth estimates on 2026-11-06 from 85.62% to 89.40%, a 3.78 percentage-point increase. The move is plausibly tied to headlines citing a smaller-than-feared loss and
Generated 2026-11-11 · news as of 2026-11-10
Current Snapshot
- Sector
- Healthcare
- Industry
- Healthcare Plans
- EPS growth next year
- 95.40%
- EPS growth this year
- -44.52%
- EPS next quarter (est)
- -$7.60
- Last price
- $443.70
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-11-12 | 95.40% | -44.52% | -$7.60 | $443.70 |
| 2026-11-11 | 95.52% | -44.71% | -$7.60 | $446.31 |
| 2026-11-10 | 95.71% | -45.17% | -$7.65 | $438.06 |
| 2026-11-09 | 95.83% | -45.29% | -$7.66 | $423.22 |
| 2026-11-07 | 89.40% | -46.17% | -$7.68 | $433.74 |
| 2026-11-06 | 89.40% | -46.17% | -$7.68 | $433.74 |
| 2026-11-05 | 85.62% | -46.56% | -$1.00 | $411.79 |
| 2026-11-04 | 85.62% | -46.56% | -$1.00 | $417.42 |
| 2026-11-03 | 85.62% | -46.56% | -$1.00 | $417.87 |
| 2026-11-02 | 85.62% | -46.56% | -$1.00 | $410.41 |
| 2026-10-31 | 85.62% | -46.56% | -$1.00 | $414.50 |
| 2026-10-30 | 85.62% | -46.56% | -$1.00 | $414.50 |
| 2026-10-29 | 85.62% | -46.56% | -$1.00 | $417.56 |
| 2026-10-28 | 85.62% | -46.56% | -$1.00 | $411.87 |
| 2026-10-27 | 85.16% | -46.56% | -$1.00 | $414.85 |
| 2026-10-26 | 85.16% | -46.56% | -$1.00 | $417.22 |
| 2026-10-23 | 85.16% | -46.56% | -$1.00 | $422.07 |
| 2026-10-22 | 85.16% | -46.56% | -$1.00 | $420.97 |
| 2026-10-21 | 85.16% | -46.56% | -$1.00 | $425.42 |
| 2026-10-20 | 85.16% | -46.56% | -$1.00 | $427.38 |
| 2026-10-19 | 85.16% | -46.56% | -$1.00 | $414.98 |
| 2026-10-16 | 85.17% | -46.56% | -$1.00 | $413.16 |
| 2026-10-15 | 85.17% | -46.56% | -$1.00 | $432.20 |
| 2026-10-14 | 85.17% | -46.56% | -$1.00 | $427.40 |
| 2026-10-13 | 85.17% | -46.56% | -$1.00 | $420.38 |
| 2026-10-12 | 85.17% | -46.56% | -$1.00 | $433.50 |
| 2026-10-11 | 86.95% | -46.56% | -$1.00 | $431.87 |
| 2026-10-10 | 86.95% | -46.56% | -$1.00 | $431.87 |
| 2026-10-09 | 86.95% | -46.56% | -$1.00 | $431.87 |
| 2026-10-08 | 84.88% | -46.56% | -$1.00 | $387.12 |
Reports Featuring HUM
Recent News
- New oncology model from Humana, Evolent and American Oncology Network eliminates prior authorization burdenBusiness Wire
- Raised Outlooks and a Cancer Approval Arrive in the Middle of Medicare Open EnrollmentPR Newswire
- Raised Outlooks and a Cancer Approval Arrive in the Middle of Medicare Open EnrollmentPR Newswire
- Humana Commences Offers to Purchase for Cash Certain of its Outstanding Debt SecuritiesBusiness Wire
- Humana Commences Offers to Purchase for Cash Certain of its Outstanding Debt SecuritiesBusiness Wire
- HUM vs UNH: valuation and profitability comparedInvesting.com
- HUM vs UNH: valuation and profitability comparedInvesting.com
- HUM vs UNH: valuation and profitability comparedInvesting.com
- Humana's Smaller-Than-Feared Loss And Raised Guidance Shift Focus To Stars Upside And A Tougher 2027 Cost TrendEarnings Whispers
- Humana's Smaller-Than-Feared Loss And Raised Guidance Shift Focus To Stars Upside And A Tougher 2027 Cost TrendEarnings Whispers
Screen Performance
Aggregate stats across all 2145 tickers our top-EPS-revision screen has flagged over the past 225 days.
- Median return since detection
- -2.9%
- % of tickers in the green
- 43%
- Median return on winners
- +22.8%
- Large revisions captured
- 2246
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
Why did Humana Inc (HUM) stock go up recently?▾
Humana Inc (HUM) stock has risen following an analyst upgrade of its next-year EPS growth estimate from 85.62% to 89.40% on 2026-11-06. Since detection, the estimate has moved up a net +6.00 pp to 95.40%. EPS estimate upgrades are among the strongest leading indicators of stock outperformance.
What is Humana Inc's next-year EPS growth estimate?▾
As of 2026-11-12, Humana Inc (HUM) has a next-year EPS growth estimate of 95.40%, based on analyst consensus.
When was the latest EPS estimate revision for HUM?▾
The most recent revision occurred on 2026-11-12, when analysts adjusted the next-year EPS growth estimate from 95.52% to 95.40%.
What sector and industry does Humana Inc belong to?▾
Humana Inc operates in the Healthcare sector, specifically the Healthcare Plans industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. HUM appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Humana Inc (HUM) appears here because it was detected by our daily top-EPS-revision-performer screen.